Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Santoni-Rugiu

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Oncogene|April 30, 2004
Cancer predisposition in mice deficient for the metastasis-associated Mts1(S100A4) geneChristina EL Naaman, Birgitte Grum-Schwensen, Ahmed Mansouri, et al.
Plos One|March 23, 2018
Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer (NSCLC)-validation in two independent cohortsIda Kappel Buhl, Eric Santoni-Rugiu, Jesper Ravn, et al.
International Journal of Molecular Sciences|September 9, 2023
Real-World Data on Combined EGFR-TKI and Crizotinib Treatment for Acquired and De Novo <i>MET</i> Amplification in Patients with Metastatic <i>EGFR</i>-Mutated NSCLCEdyta M Urbanska, Morten Grauslund, Peter R Koffeldt, et al.
Clinical Lung Cancer|March 28, 2026
Durable Response to Sequential ROS1-TKIs in Metastatic Squamous NSCLC With EZR-ROS1 Fusion: A Case ReportAnne-Mette A Konradsen, Eva S Petersson, Morten Grauslund, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|March 30, 2026
Rationale and Design of the MIA Trial: A Proof-of-Concept Study of Minimally Invasive Autopsy in an Infectious Cause of Death in a Scandinavian ICU SettingFridtjof Gjerdrum Helgesen, Birgitte Grønkær Toft, Camilla Musaeus Donato, et al.
Oncotarget|March 13, 2019
Application of cell-free DNA for genomic tumor profiling: a feasibility studyLise B Ahlborn, Kristoffer S Rohrberg, Migle Gabrielaite, et al.
The Journal of Cell Biology|October 28, 2018
Immune regulation by fibroblasts in tissue injury depends on uPARAP-mediated uptake of collectinsHenrik J Jürgensen, Kirstine S Nørregaard, Megan M Sibree, et al.
Translational Lung Cancer Research|June 10, 2024
A rare case report of a primary lung cancer comprising adenocarcinoma and atypical carcinoid tumor, with the carcinoid component harboring <i>EML4-ALK</i> rearrangementWenbin Hu, Jiaming Zhao, Guoxia Wang, et al.
BMC Cancer|February 12, 2011
The level of claudin-7 is reduced as an early event in colorectal carcinogenesisJette Bornholdt, Stine Friis, Sine Godiksen, et al.
Translational Lung Cancer Research|April 18, 2025
Targeting of arachidonic acid-modulated autophagy to enhance the sensitivity of <i>ROS1</i> <sup>+</sup> or <i>ALK</i> <sup>+</sup> non-small cell lung cancer to crizotinib therapyHui Jie, Hongjin Lai, Zihuai Wang, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Oncogene|April 30, 2004
Cancer predisposition in mice deficient for the metastasis-associated Mts1(S100A4) geneChristina EL Naaman, Birgitte Grum-Schwensen, Ahmed Mansouri, et al.
Plos One|March 23, 2018
Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer (NSCLC)-validation in two independent cohortsIda Kappel Buhl, Eric Santoni-Rugiu, Jesper Ravn, et al.
International Journal of Molecular Sciences|September 9, 2023
Real-World Data on Combined EGFR-TKI and Crizotinib Treatment for Acquired and De Novo <i>MET</i> Amplification in Patients with Metastatic <i>EGFR</i>-Mutated NSCLCEdyta M Urbanska, Morten Grauslund, Peter R Koffeldt, et al.
Clinical Lung Cancer|March 28, 2026
Durable Response to Sequential ROS1-TKIs in Metastatic Squamous NSCLC With EZR-ROS1 Fusion: A Case ReportAnne-Mette A Konradsen, Eva S Petersson, Morten Grauslund, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|March 30, 2026
Rationale and Design of the MIA Trial: A Proof-of-Concept Study of Minimally Invasive Autopsy in an Infectious Cause of Death in a Scandinavian ICU SettingFridtjof Gjerdrum Helgesen, Birgitte Grønkær Toft, Camilla Musaeus Donato, et al.
Oncotarget|March 13, 2019
Application of cell-free DNA for genomic tumor profiling: a feasibility studyLise B Ahlborn, Kristoffer S Rohrberg, Migle Gabrielaite, et al.
The Journal of Cell Biology|October 28, 2018
Immune regulation by fibroblasts in tissue injury depends on uPARAP-mediated uptake of collectinsHenrik J Jürgensen, Kirstine S Nørregaard, Megan M Sibree, et al.
Translational Lung Cancer Research|June 10, 2024
A rare case report of a primary lung cancer comprising adenocarcinoma and atypical carcinoid tumor, with the carcinoid component harboring <i>EML4-ALK</i> rearrangementWenbin Hu, Jiaming Zhao, Guoxia Wang, et al.
BMC Cancer|February 12, 2011
The level of claudin-7 is reduced as an early event in colorectal carcinogenesisJette Bornholdt, Stine Friis, Sine Godiksen, et al.
Translational Lung Cancer Research|April 18, 2025
Targeting of arachidonic acid-modulated autophagy to enhance the sensitivity of <i>ROS1</i> <sup>+</sup> or <i>ALK</i> <sup>+</sup> non-small cell lung cancer to crizotinib therapyHui Jie, Hongjin Lai, Zihuai Wang, et al.
Pageof 10